These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3081572)

  • 1. Molecular forms of human growth hormone secreted in vivo: nonspecificity of secretory stimuli.
    Baumann G; Stolar MW
    J Clin Endocrinol Metab; 1986 Apr; 62(4):789-90. PubMed ID: 3081572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular nature of circulating growth hormone in normal and acromegalic man: evidence for a principal and minor monomeric forms.
    Baumann G; MacCart JG; Amburn K
    J Clin Endocrinol Metab; 1983 May; 56(5):946-52. PubMed ID: 6339541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating growth hormone forms after stimulation of pituitary secretion with growth hormone-releasing factor in man.
    Stolar MW; Baumann G; Vance ML; Thorner MO
    J Clin Endocrinol Metab; 1984 Aug; 59(2):235-9. PubMed ID: 6429181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulsatile growth hormone secretion in patients with acromegaly and normal men: the effects of growth hormone-releasing hormone infusion.
    Gelato MC; Oldfield E; Loriaux DL; Merriam GR
    J Clin Endocrinol Metab; 1990 Sep; 71(3):585-90. PubMed ID: 2118536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary growth hormone in man: evidence for multiple molecular forms.
    Baumann G; Abramson EC
    J Clin Endocrinol Metab; 1983 Feb; 56(2):305-11. PubMed ID: 6337176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum concentration of 20K human growth hormone (20K hGH) measured by a specific enzyme-linked immunosorbent assay. Study Group of 20K hGH.
    Tsushima T; Katoh Y; Miyachi Y; Chihara K; Teramoto A; Irie M; Hashimoto Y
    J Clin Endocrinol Metab; 1999 Jan; 84(1):317-22. PubMed ID: 9920101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular forms of circulating growth hormone during spontaneous secretory episodes and in the basal state.
    Baumann G; Stolar MW; Amburn K
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1216-20. PubMed ID: 3889030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty-kilodalton human growth hormone (20K hGH) secretion from growth hormone-secreting pituitary adenoma cells in vitro.
    Murakami Y; Mori T; Koshimura K; Kurosaki M; Takenobu A; Hashimoto Y; Kato Y
    Endocr J; 2000 Oct; 47(5):563-8. PubMed ID: 11200936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased growth hormone pulse frequency in acromegaly.
    Barkan AL; Stred SE; Reno K; Markovs M; Hopwood NJ; Kelch RP; Beitins IZ
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1225-33. PubMed ID: 2511221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the sensitivity of growth hormone secretion to somatostatin in vivo and in vitro in acromegaly.
    Kelijman M; Williams TC; Downs TR; Frohman LA
    J Clin Endocrinol Metab; 1988 Nov; 67(5):958-63. PubMed ID: 2903171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.
    Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N
    J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly.
    Losa M; Schopohl J; König A; Müller OA; von Werder K
    J Clin Endocrinol Metab; 1986 Aug; 63(2):475-80. PubMed ID: 3088026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone pulsatility in active and cured acromegalic subjects.
    Semer M; Faria AC; Nery M; Salgado LR; Knoepfelmacher M; Wajchenberg BL; Liberman B
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3767-70. PubMed ID: 8530632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma "big" and "big-big" growth hormone (GH) in man: an oligomeric series composed of structurally diverse GH monomers.
    Stolar MW; Amburn K; Baumann G
    J Clin Endocrinol Metab; 1984 Aug; 59(2):212-8. PubMed ID: 6376529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone isoforms in acromegalic patients before and after treatment with octreotide LAR.
    Lima GA; Wu Z; Silva CM; Barbosa FR; Dias JS; Schrank Y; Strasburger CJ; Gadelha MR
    Growth Horm IGF Res; 2010 Apr; 20(2):87-92. PubMed ID: 19884028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of growth hormone (GH) release by individual pituitary adenoma cells from acromegalic patients, as determined by the reverse hemolytic plaque assay: effects of SMS 201-995, GH-releasing hormone and thyrotropin-releasing hormone.
    Hofland LJ; van Koetsveld PM; van Vroonhoven CC; Stefanko SZ; Lamberts SW
    J Clin Endocrinol Metab; 1989 Mar; 68(3):613-20. PubMed ID: 2493040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas.
    Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1148-53. PubMed ID: 3923021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression by thyrotropin-releasing hormone (TRH) of human growth hormone release induced by L-dopa.
    Maeda K; Kato Y; Chihara K; Ogo S; Iwasaki Y
    J Clin Endocrinol Metab; 1975 Aug; 41(2):408-11. PubMed ID: 239963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in growth hormone (GH) secretion induced by human pancreatic GH releasing hormone-44 in acromegaly: a comparison with thyrotropin-releasing hormone and bromocriptine.
    Chiodini PG; Liuzzi A; Dallabonzana D; Oppizzi G; Verde GG
    J Clin Endocrinol Metab; 1985 Jan; 60(1):48-52. PubMed ID: 3917270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.